Zurich Medical
Zurich Medical Inc. is a Minneapolis-based private medical device company that develops and sells the FDA-cleared, CE-marked Zurich Pressure Guidewire System Model 100 — a single-use, all-in-one FFR measurement device targeting interventional cardiologists and cardiac catheterization labs in North America and Europe.
- Company typePrivate
- Founded1977
- HeadquartersMinneapolis, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Zurich Medical does
Zurich Medical Inc. is a privately held medical device company headquartered in Minneapolis, Minnesota that develops and commercializes cardiovascular diagnostic devices. The company's flagship product is the Zurich Pressure Guidewire System Model 100, an FDA-cleared and CE-marked fractional flow reserve (FFR) measurement system used by interventional cardiologists during coronary angiography to assess the physiological significance of arterial stenoses and guide percutaneous coronary intervention (PCI) decisions. The system integrates a pressure-sensing guidewire with an advanced MEMS piezoresistive sensor, a portable one-time-use display, a shapeable radiopaque distal tip, and an ergonomic single-button handle — marketed as the first all-in-one FFR system requiring no capital equipment purchase or maintenance.
Zurich Medical generates revenue through direct hardware sales of single-use Pressure Guidewire Systems to hospitals and cardiac catheterization labs, primarily in North America and Europe, employing a field sales motion targeting interventional cardiologists. The company holds 12 granted patents across the US, EU, China, Japan, Korea, and Australia covering its pressure guidewire technology, and supports customers with clinical education resources and US reimbursement coding guidance (CPT codes +93571, +93572, HCPCS C-Code C1769). Its core differentiator is the elimination of capital equipment costs through a disposable display architecture, positioning it as a cost-effective alternative to incumbents such as Philips and Abbott in the FFR market. The company is led by Chairman and CEO Paul J. Gam and reports a headcount of 11-50 employees.
Zurich Medical firmographics
Firmographics- Name
- Zurich Medical
- Legal name
- Zurich Medical Inc.
- Website
- https://zurichmed.com
- Company type
- Private
- Founded year
- 1977
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Zurich Medical Inc. is a Minneapolis-based private medical device company that develops and sells the FDA-cleared, CE-marked Zurich Pressure Guidewire System Model 100 — a single-use, all-in-one FFR measurement device targeting interventional cardiologists and cardiac catheterization labs in North America and Europe.
- Ownership category
- akta.pro rank
Zurich Medical industry classification
Industry- Product category
- Interventional Cardiology Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)
Keywords
Where Zurich Medical is headquartered
LocationHeadquarters
- HQ city
- Minneapolis
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Zurich Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales
Revenue model
- Medical Device Sales: Zurich Medical generates revenue through the sale of its Pressure Guidewire System Model 100 and related single-use components. The company sells directly to hospitals and cardiac catheterization labs, with products designed for one-time use per procedure.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Zurich Medical product offering
Product offeringCore offering
Zurich Medical develops and sells the Zurich Pressure Guidewire System Model 100, an FDA-cleared and CE-marked medical device for measuring Fractional Flow Reserve (FFR) during coronary angiography. The system combines a pressure-sensing guidewire with an advanced MEMS piezoresistive sensor and a single-use portable display, eliminating the need for hospitals to purchase capital equipment. It is sold to interventional cardiologists and cardiac catheterization labs for assessing the significance of coronary artery stenoses.
Product overview
Zurich Medical offers a single unified product — the Zurich Pressure Guidewire System Model 100™ — which is an FFR (Fractional Flow Reserve) measurement system for cardiovascular assessment. The system comprises a pressure-sensing guidewire with an advanced MEMS piezoresistive sensor, a one-time-use portable display, and accessories including an ergonomic handle and shapeable radiopaque distal tip. This integrated medical device is designed for single-patient use, eliminating the need for healthcare facilities to purchase and maintain expensive capital equipment. The system has received both FDA 510(k) clearance and CE Mark approval for clinical use.
Differentiator
Problem solved
Functional benefit
Products and services
- Zurich Pressure Guidewire System Model 100 An FDA-cleared and CE-marked fractional flow reserve (FFR) measurement system consisting of a pressure-sensing guidewire with an advanced MEMS piezoresistive sensor and a portable one-time-use display. Measures blood pressure and flow through arterial blockages to assess the significance of coronary stenoses without requiring capital equipment. Designed for interventional cardiologists and cardiac catheterization labs performing percutaneous coronary interventions.
Quantifiable outcome
- FFR < 0.80 threshold indicates intervention required per medical guidelines
- +2 more outcomes
Companies that use Zurich Medical
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
Zurich Medical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Zurich Medical partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- MedQ Consultants B.V.coreEC Authorized Representative (GPG) for Zurich Medical in the European Union. Located at Baanstraat 110, 6372 AH Landgraaf, The Netherlands. Provides regulatory compliance representation for European market access.
- MedR-AR Services B.V.coreEC Authorized Representative (ZMAC) for Zurich Medical in the European Union. Located at Kloosterweg 1, 6412 CN Heerlen, The Netherlands. Provides regulatory compliance representation for European market access.
Scale indicators1 record
Recent moves6 records
Expansion highlights4 records
Zurich Medical competitors and assessment
Company assessmentEmerging players
- CathWorks: CathWorks markets the FFRangio system, performing computational FFR from standard angiograms — a wire-free alternative that could erode demand for invasive FFR guidewires like Zurich's.
- HeartFlow: HeartFlow pioneered non-invasive FFR-CT analysis — a wire-free alternative modality that competes with invasive FFR guidewires for diagnosing coronary stenosis significance.
- Medis Medical Imaging: Medis offers QFR (quantitative flow ratio), a computational FFR alternative derived from angiographic images — an emerging modality competing against traditional invasive FFR guidewires.
Broad incumbents
- GE HealthCare: GE HealthCare provides interventional cardiology imaging and integrated cath-lab systems — a broader incumbent whose cardiology franchise competes for cath-lab capital and procedural budgets.
- Siemens Healthineers: Siemens Healthineers participates in interventional cardiology imaging and integrated cath-lab solutions — a broader incumbent whose cath-lab platform competes for the same hospital budget pool as Zurich's FFR system.
- Boston Scientific: Boston Scientific markets the Comet FFR guidewire and broader interventional cardiology portfolio — a large, multi-product incumbent against which Zurich's single-product FFR offering must compete on price and workflow.
- Philips: Philips (via Volcano/PressureWire-derived assets) sells Verrata and SyncVision — a directly competitive FFR/iFR guidewire offering bundled with Philips interventional cardiology imaging and physiology systems.
- Abbott: Abbott's Vascular division sells PressureWire (certus, Aeris) — the long-standing market-leading FFR guidewire with deep clinical relationships and integrated cath-lab ecosystem, the direct incumbent Zurich competes against.
Direct peers
- Opsens: Opsens manufactures the OptoWire, an FFR guidewire using fiber-optic sensing technology — a direct technical peer in the invasive FFR guidewire category Zurich addresses.
- ACIST Medical Systems: ACIST (a Bracco subsidiary) sells the ACIST Navvus microcatheter and HemoSphere console — a directly competitive FFR measurement offering in the cath lab.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights7 records
Customer concentration
Zurich Medical social profiles
Digital presenceZurich Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Zurich Medical leadership team
Management profileNumber of profiles
Profiles1 record
Zurich Medical funding detail
Funding detailFunding overview
Funding rounds2 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Zurich Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Zurich Medical
What does Zurich Medical do?
Zurich Medical develops and sells the Zurich Pressure Guidewire System Model 100, an FDA-cleared and CE-marked medical device for measuring Fractional Flow Reserve (FFR) during coronary angiography. The system combines a pressure-sensing guidewire with an advanced MEMS piezoresistive sensor and a single-use portable display, eliminating the need for hospitals to purchase capital equipment. It is sold to interventional cardiologists and cardiac catheterization labs for assessing the significance of coronary artery stenoses.
Is Zurich Medical a public or private company?
Zurich Medical is a private company. It is classified as unknown and is currently operating.
When was Zurich Medical founded?
Zurich Medical was founded in 1977. It employs 11 to 50 people.
Where is Zurich Medical based?
Zurich Medical is headquartered in Minneapolis, United States, in the North America region.
How does Zurich Medical make money?
One revenue line is on record: medical Device Sales.
Who are Zurich Medical's main competitors?
Emerging players on record are CathWorks, HeartFlow and Medis Medical Imaging. Broad incumbents are GE HealthCare, Siemens Healthineers, Boston Scientific, Philips and Abbott. Direct peers are Opsens and ACIST Medical Systems.
Does Zurich Medical have an API?
No public API is recorded for Zurich Medical.
What industry is Zurich Medical in?
Zurich Medical's product category is Interventional Cardiology Devices. Its primary akta.pro industry code is HLAHAFAI, Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT). Its NAICS code is 334510 and its SIC code is 3841.